Regarding Alzheimer’s disease, a cross-sectional study reported substantially higher levels of circulating MIG (CXCL9) in patients with Alzheimer’s disease compared to non-cognitively impaired and mildly-cognitively impaired participants (Lee et al., 2008). The gene discussed is CXCL9; the disease is early-onset autosomal dominant Alzheimer disease.